Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model
- Patrick P.L. Lam12,
- Yuk-Man Leung12,
- Laura Sheu12,
- James Ellis3,
- Robert G. Tsushima12,
- Lucy R. Osborne14 and
- Herbert Y. Gaisano12
- 1Department of Medicine, University of Toronto, Toronto, Canada
- 2Department of Physiology, University of Toronto, Toronto, Canada
- 3Program in Developmental Biology, Sick Kids Hospital, Toronto, Canada
- 4Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
- Address correspondence and reprint requests to Herbert Y. Gaisano, MD, University of Toronto, Room 7226, Medical Science Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: herbert.gaisano{at}utoronto.ca. Or Lucy R. Osborne, PhD, University of Toronto, Room 7238, Medical Science Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: lucy.osborne{at}utoronto.ca
Abstract
Soluble N-ethylmaleimide–sensitive factor (NSF) attachment protein receptor (SNARE) protein syntaxin-1A (STX-1A) plays a role not only in exocytosis, but also binds and regulates Ca2+ and K+ (voltage-gated K+ and ATP-sensitive K+ channels) to influence the sequence of events leading to secretion. Islet levels of STX-1A and cognate SNARE proteins are reduced in type 2 diabetic rodents, suggesting their role in dysregulated insulin secretion contributing to the abnormal glucose homeostasis. We investigated the specific role of STX-1A in pancreatic β-cells by generating transgenic mice, which express a moderately increased level (∼30% higher) of STX-1A in pancreatic islets (hereafter called STX-1A mice). The STX-1A mice displayed fasting hyperglycemia and a more sustained elevation of plasma glucose levels after an intraperitoneal glucose tolerance test, with correspondingly reduced plasma insulin levels. Surprisingly, β-cells from the STX-1A male mice also exhibited abnormal insulin tolerance. To unequivocally determine the β-cell secretory defects, we used single-cell analyses of exocytosis by patch clamp membrane capacitance measurements and ion channel recordings. Depolarization-evoked membrane capacitance increases were reduced in the STX-1A mouse islet β-cells. The STX-1A mouse also exhibited reduced currents through the Ca2+ channels but little change in the voltage-gated K+ channel or ATP-sensitive K+ channel. These results suggest that fluctuation of islet STX-1A levels in diabetes could influence the pathological and differential regulation of β-cell ion channels and the exocytotic machinery, collectively contributing to the impaired insulin secretion.
- Cm, membrane capacitance
- GST, glutathione S-transferase
- IPGTT, intraperitoneal glucose tolerance test
- KATP channel, ATP-sensitive K+ channel
- Kv channel, voltage-gated potassium channel
- NSF, N-ethylmaleimide–sensitive factor
- SNAP-25, synaptosome-associated protein of 25 kDa
- SNARE, soluble NSF attachment protein receptor
- STX-1A, syntaxin-1A
- TEA, tetraethylammonium
- VAMP-2, vesicle-associated membrane protein 2
- WBS, Williams-Beuren syndrome
Footnotes
-
P.P.L.L. and Y.-M.L. contributed equally to this work.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted June 7, 2005.
- Received November 23, 2004.
- DIABETES














